GE HealthCare Technologies Inc.
GEHCUS売上高
$20.6B
百万USD
営業利益
$2.8B
百万USD
純利益
$2.1B
百万USD
ROE
20.1%
最新FY
EPS
$4.55
USD / 株
配当
$0.14
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2022 | FY | - | - | - |
| FY2023 | Q1 | $4.7B | $372M | $0.41 |
| FY2023 | Q2 | $4.8B | $418M | $0.91 |
| FY2023 | Q3 | $4.8B | $375M | $0.82 |
| FY2023 | FY | $19.6B | $1.6B | $3.03 |
| FY2024 | Q1 | $4.7B | $374M | $0.81 |
| FY2024 | Q2 | $4.8B | $428M | $0.93 |
| FY2024 | Q3 | $4.9B | $470M | $1.02 |
| FY2024 | FY | $19.7B | $2.0B | $4.34 |
| FY2025 | Q1 | $4.8B | $564M | $1.23 |
| FY2025 | Q2 | $5.0B | $486M | $1.06 |
| FY2025 | Q3 | $5.1B | $446M | $0.98 |
| FY2025 | FY | $20.6B | $2.1B | $4.55 |
| FY2026 | Q1 | $5.1B | $389M | $0.85 |
財務データ
| 指標 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| 売上高 | - | $19.6B | $19.7B | $20.6B |
| 営業利益 | - | $2.4B | $2.6B | $2.8B |
| 純利益 | - | $1.6B | $2.0B | $2.1B |
| 総資産 | - | $32.5B | $33.1B | $36.9B |
| 純資産 | - | $7.1B | $8.5B | $10.4B |
| 自己資本 | - | $7.1B | $8.4B | $10.4B |
| 営業CF | - | - | - | - |
| EPS | - | $3.03 | $4.34 | $4.55 |
| BPS | - | $15.66 | $18.47 | $22.77 |
| ROE | - | 22.0% | 23.6% | 20.1% |